Lords Mark Industries Limited Awarded with Certificate of Honour for Innovation in Diagnostic Technology at the NavaBharat Healthcare Summit 2025

NewsVoir
Mumbai (Maharashtra) [India], June 18: Lords Mark Industries Limited, a distinguished company known for its diverse portfolio and one of the leading innovator in diagnostic technology solutions, has been awarded the prestigious Certificate of Honour for Innovation in Diagnostic Technology at NavaBharat Healthcare Summit 2025. The award was presented by Hon. Union Minister of State for Health & Family Welfare, Govt. of India, Smt. Anupriya Patel, in recognition of the company's ground-breaking contributions to advancing diagnostic capabilities in the healthcare sector.
The award was received by Mr. Manav Teli, Executive Director of Lords Mark Industries Limited, during the ceremony held to honor organizations making significant strides in healthcare innovation.
The Certificate of Honour acknowledges Lords Mark Industries Limited's contributions to the advancement of diagnostic technology, which plays a crucial role in early disease detection, accurate diagnosis, and improved patient care across India's healthcare system.
On the occasion, Mr. Manav Teli, Executive Director, Lords Mark Industries Limited said, "We are deeply honoured to receive this recognition as this award validates our commitment to developing cutting-edge diagnostic technologies that improve patient outcomes and support healthcare professionals in delivering better care. Our team's dedication to innovation and excellence has made this achievement possible, and we remain committed to pushing the boundaries of multiple possibilities in diagnostic technology."
This recognition also underscores Lords Mark Industries Limited's position as a forward-thinking organization dedicated to transforming healthcare through technological innovation.
Lord's Mark Industries operates through key subsidiaries, Lord's Mark Biotech, Lords Mark Microbiotech, Lords Automative and Lord's Mark Insurance Broking Limited (bimaakawach) along with verticals in renewable energy products and paper. Committed to innovation and excellence, the company continues to expand while upholding the highest quality standards. Diversification remains the foundation of Lord's Mark Industries' sustained growth and success. LordsMed, one of the brands of Lord's Mark Industries is making a grand and significant mark in the diagnostic sector.
Incorporated in 1998, Lord's Mark Industries Ltd. (Lord's) has made impressive growth starting from paper to LED to Renewable energy and making grand in the medical diagnostic industry. Lord's and its subsidiaries have made a mark in Electric Vehicle, Genome Testing, Pharma and Healthcare. Growth through diversification has become the trend setter and has been the cornerstone of success at Lord's.
Website - lordsmark.com.
(ADVERTORIAL DISCLAIMER: The above press release has been provided by NewsVoir. ANI will not be responsible in any way for the content of the same)

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Business Standard

5 days ago

• Business Standard

Lords Mark Industries Limited Awarded with Certificate of Honour for Innovation in Diagnostic Technology at the NavaBharat Healthcare Summit 2025

NewsVoir Mumbai (Maharashtra) [India], June 18: Lords Mark Industries Limited, a distinguished company known for its diverse portfolio and one of the leading innovator in diagnostic technology solutions, has been awarded the prestigious Certificate of Honour for Innovation in Diagnostic Technology at NavaBharat Healthcare Summit 2025. The award was presented by Hon. Union Minister of State for Health & Family Welfare, Govt. of India, Smt. Anupriya Patel, in recognition of the company's ground-breaking contributions to advancing diagnostic capabilities in the healthcare sector. The award was received by Mr. Manav Teli, Executive Director of Lords Mark Industries Limited, during the ceremony held to honor organizations making significant strides in healthcare innovation. The Certificate of Honour acknowledges Lords Mark Industries Limited's contributions to the advancement of diagnostic technology, which plays a crucial role in early disease detection, accurate diagnosis, and improved patient care across India's healthcare system. On the occasion, Mr. Manav Teli, Executive Director, Lords Mark Industries Limited said, "We are deeply honoured to receive this recognition as this award validates our commitment to developing cutting-edge diagnostic technologies that improve patient outcomes and support healthcare professionals in delivering better care. Our team's dedication to innovation and excellence has made this achievement possible, and we remain committed to pushing the boundaries of multiple possibilities in diagnostic technology." This recognition also underscores Lords Mark Industries Limited's position as a forward-thinking organization dedicated to transforming healthcare through technological innovation. Lord's Mark Industries operates through key subsidiaries, Lord's Mark Biotech, Lords Mark Microbiotech, Lords Automative and Lord's Mark Insurance Broking Limited (bimaakawach) along with verticals in renewable energy products and paper. Committed to innovation and excellence, the company continues to expand while upholding the highest quality standards. Diversification remains the foundation of Lord's Mark Industries' sustained growth and success. LordsMed, one of the brands of Lord's Mark Industries is making a grand and significant mark in the diagnostic sector. Incorporated in 1998, Lord's Mark Industries Ltd. (Lord's) has made impressive growth starting from paper to LED to Renewable energy and making grand in the medical diagnostic industry. Lord's and its subsidiaries have made a mark in Electric Vehicle, Genome Testing, Pharma and Healthcare. Growth through diversification has become the trend setter and has been the cornerstone of success at Lord's. Website - (ADVERTORIAL DISCLAIMER: The above press release has been provided by NewsVoir. ANI will not be responsible in any way for the content of the same)

Fashion Value Chain

5 days ago

• Fashion Value Chain

Lords Mark Industries Limited Awarded with Certificate of Honour for Innovation in Diagnostic Technology at the NavaBharat Healthcare Summit 2025

Lords Mark Industries Limited, a distinguished company known for its diverse portfolio and one of the leading innovator in diagnostic technology solutions, has been awarded the prestigious Certificate of Honour for Innovation in Diagnostic Technology at NavaBharat Healthcare Summit 2025. The award was presented by Hon. Union Minister of State for Health & Family Welfare, Govt. of India, Smt. Anupriya Patel, in recognition of the companys ground-breaking contributions to advancing diagnostic capabilities in the healthcare sector. Lords Mark Industries Limited Awarded with Certificate of Honour for Innovation in Diagnostic Technology at the NavaBharat Healthcare Summit 2025 The award was received by Mr. Manav Teli, Executive Director of Lords Mark Industries Limited, during the ceremony held to honor organizations making significant strides in healthcare innovation. Mr. Manav Teli, Executive Director, Lords Mark Industries Limited with Certificate of Honour for Innovation in Diagnostic Technology at the NavaBharat Healthcare Summit 2025 The Certificate of Honour acknowledges Lords Mark Industries Limiteds contributions to the advancement of diagnostic technology, which plays a crucial role in early disease detection, accurate diagnosis, and improved patient care across Indias healthcare system. On the occasion, Mr. Manav Teli, Executive Director, Lords Mark Industries Limited said, 'We are deeply honoured to receive this recognition as this award validates our commitment to developing cutting-edge diagnostic technologies that improve patient outcomes and support healthcare professionals in delivering better care. Our teams dedication to innovation and excellence has made this achievement possible, and we remain committed to pushing the boundaries of multiple possibilities in diagnostic technology.' This recognition also underscores Lords Mark Industries Limiteds position as a forward-thinking organization dedicated to transforming healthcare through technological innovation. Lord's Mark Industries operates through key subsidiaries, Lord's Mark Biotech, Lords Mark Microbiotech, Lords Automative and Lord's Mark Insurance Broking Limited (bimaakawach) along with verticals in renewable energy products and paper. Committed to innovation and excellence, the company continues to expand while upholding the highest quality standards. Diversification remains the foundation of Lord's Mark Industries sustained growth and success. LordsMed, one of the brands of Lords Mark Industries is making a grand and significant mark in the diagnostic sector. About Lord's Mark Industries Ltd Incorporated in 1998, Lord's Mark Industries Ltd. (Lord's) has made impressive growth starting from paper to LED to Renewable energy and making grand in the medical diagnostic industry. Lord's and its subsidiaries have made a mark in Electric Vehicle, Genome Testing, Pharma and Healthcare. Growth through diversification has become the trend setter and has been the cornerstone of success at Lord's. Website –

United News of India

6 days ago

• United News of India

70 pc of the WHO's total vaccines are from India: Govt

New Delhi, June 16 (UNI) Reaffirming India's pivotal role in the global pharmaceutical industry, Minister of State for Health and Family Welfare, Anupriya Patel on Monday pointed out that 70 percent of the World Health Organisation's (WHO) total vaccines are sourced from India. She also highlighted that 14 percent of generics imported by the United States come from India, further showcasing India's dominance in the pharmaceutical sector. The Forum, organised by the Indian Pharmacopoeia Commission (IPC) under the Union Health Ministry, brings together an international delegation of policymakers, drug regulators, and experts from 24 countries including Liberia, Togo, Mali, and Papua New Guinea, among others. Patel also praised India's flagship initiative, the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), which aims to provide affordable medicines to all citizens. She further noted that the Jan Aushadhi Kendras, which are integral to this program, serve as "shining examples of India's commitment to making quality medicines accessible to all." "These centres have proven to be vital in reducing out-of-pocket medical expenses for millions of Indians," Patel added, underscoring the importance of such initiatives in improving public health. 'As much as 70% of WHO's vaccines come from India…India is the world's top producer of generics, with 14% of the generics imported by the US sourced from India. We also have the highest number of US FDA-recognized drug manufacturing plants,' she said. Furthermore, Patel highlighted India's robust regulatory framework, noting that the country retains the WHO's Global Benchmarking Tool (GBT) Maturity Level 3 (ML3) status. This, she explained, reflects India's commitment to maintaining high standards in drug regulation. The Indian Pharmacopoeia, she added, is now recognised by 15 countries worldwide, with Cuba being the most recent to adopt it as a standard for drug quality. Union Health Secretary, Punya Salila Srivastava, also addressed the forum, pointing out that over 1.75 lakh Ayushman Arogya Mandirs (previously known as Health and Wellness Centres) have been established across India, where free drugs and diagnostics are provided to the public. She also discussed the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY), a health assurance scheme that offers up to ₹5 lakh coverage per family, benefiting 40% of India's population. The scheme has helped reduce out-of-pocket health expenditure from 70% in 2004 to just 40% today. UNI AJ SSP